CIK 0001531177 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800625749
- Phone
- (415) 889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $652,777
- in 5 filings, $653K under 10b5-1 plans
Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
- Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-07 | Badawi Paul President and CEO | Shares withheld for taxes | −12,047 | $3.58 | $43K | 5,701,150 |
| 2025-01-03 | Badawi David Chief Technology Officer | Sale | −3,111 | $3.52 | $11K | 1,753,370 |
| 2025-01-03 | HAYDEN JEREMY B. Chief Legal Officer | Sale | −4,864 | $3.52 | $17K | 153,823 |
| 2025-01-03 | Bauerlein Alison Chief Financial Officer | Sale | −10,102 | $3.52 | $36K | 382,453 |
| 2025-01-02 | Badawi Paul President and CEO | Sale | −12,236 | $3.60 | $44K | 5,713,197 |
| 2022-09-21 | Badawi David Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −40,000 | 42,540 |
Page 7 of 7 · 126 trades